Skip to main content
Caplight Logo









Intrepid Labs

Intrepid Labs

Private
TorontoHealthcare & Life Scienceshttps://intrepidlabs.tech/

Last Round

Seed

May 12, 2025

Total Funding Raised

$15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Intrepid Labs is a biotechnology company that utilizes its proprietary AI-driven robotic platform, Valiant, to accelerate drug formulation and therapeutic development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

drug formulationself-driving labautonomous laboratoryrobotic automationAI-driven drug discoverycontract research organizationCROcontract development and manufacturing organizationCDMOactive learningclosed-loop experimentationbiotech R&Ddrug delivery technologylab automationAI for science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intrepid Labs Comparables

Compare Intrepid Labs with similar companies based on industry and business-model similarity.

Intrepid Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Persist AI
88%
Implexis
78%
METiS Pharmaceuticals
75%

Intrepid Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 12, 2025
Pre SeedAug 30, 2023

Key People

Founding team and executive leadership

Christine Allen

Co-Founder And CEO

Founding Team

Intrepid Labs Investors

Notable investors and investment history

Intrepid Labs investors
InvestorRounds
Propagator VenturesSeed, Pre Seed
Radical VenturesSeed, Pre Seed
AVANT BIOSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 25, 2026

    Grew 23% QoQ, from 22 to 27 employees.

  • May 12, 2025

    $7M raised in Seed round.

Intrepid Labs Filings

Explore SEC and related filing metadata, where available.

Intrepid Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Intrepid Labs's valuation, stock price, and market status.

Is Intrepid Labs a public or private company?

Intrepid Labs is a private company.

What is the current stock price of Intrepid Labs?

Intrepid Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Intrepid Labs worth (valuation)?

Valuation information for Intrepid Labs is not publicly available.

Can I buy Intrepid Labs stock?

Intrepid Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Intrepid Labs's last funding round?

Intrepid Labs's most recent funding round was Seed on May 12, 2025.

Who are the main investors in Intrepid Labs?

Key investors in Intrepid Labs include Propagator Ventures, Radical Ventures, AVANT BIO.

Will Intrepid Labs IPO soon?

No public IPO plans have been announced for Intrepid Labs.

How can I track Intrepid Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intrepid Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range23
Year Founded2023
Last FundingMay 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?